These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1632567)

  • 1. Differential exercise effects of captopril and nadolol in patients with essential hypertension.
    Kostis JB; Shindler DM; Moreyra AE; Ruddy MC; Schneider S; Cosgrove N
    Angiology; 1992 Aug; 43(8):647-52. PubMed ID: 1632567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive effects of verapamil, captopril and their combination at rest and during dynamic exercise.
    Di Somma S; Petitto M; Liguori V; Carotenuto A; Paulucci A; De Divitiis O
    Arzneimittelforschung; 1992 Feb; 42(2):103-7. PubMed ID: 1610414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive activity and duration of action of dilevalol in hypertensive patients at rest and during exercise. A comparison with captopril.
    Fogari R; Poletti L; Tettamanti F; Cesana B; Savonitto S
    G Ital Cardiol; 1990 Apr; 20(4):309-15. PubMed ID: 2197158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enalapril versus combined enalapril and nadolol treatment: effects on blood pressure, heart rate, humoral variables, and plasma potassium at rest and during exercise in hypertensive patients.
    Sullivan PA; Daly B; O'Connor R
    Cardiovasc Drugs Ther; 1992 Jun; 6(3):261-5. PubMed ID: 1637731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effects of diltiazem sustained-release and captopril on blood pressure control and plasma lipoproteins in primary hypertension: a randomized, double-blind, crossover study.
    Lacourcière Y; Poirier L; Boucher S; Spenard J
    J Hum Hypertens; 1990 Oct; 4(5):553-6. PubMed ID: 2283645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of captopril and nadolol on renal hemodynamics in patients with essential hypertension.
    Zhu ZH; An R; Zhang YX; Gong PL; Chen H; Zen FD
    J Tongji Med Univ; 1994; 14(1):45-8. PubMed ID: 7877194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of captopril as single therapy in hypertension and angina pectoris.
    Akhras F; Jackson G
    Int J Cardiol; 1991 Nov; 33(2):259-66. PubMed ID: 1743787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Life quality in patients under hypotensive treatment.
    Pupita F; Ansuini R; Belogi M; Campolucci G; Gaggi S; Pupita G
    Int J Clin Pharmacol Res; 1987; 7(1):13-7. PubMed ID: 3294614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postexercise hypotension induced by low-intensity resistance exercise in hypertensive women receiving captopril.
    Melo CM; Alencar Filho AC; Tinucci T; Mion D; Forjaz CL
    Blood Press Monit; 2006 Aug; 11(4):183-9. PubMed ID: 16810028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effects of amlodipine and captopril on clinic and ambulatory blood pressure.
    Lacourcière Y; Poirier L; Provencher P
    J Hum Hypertens; 1992 Dec; 6 Suppl 1():S25-8. PubMed ID: 1293305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Captopril or nifedipine? Comparison of rest and exercise acute effects and long-term therapy in chronic isolated asymptomatic moderate to severe aortic regurgitation.
    Banaszewski M; Rydlewska-Sadowska W; Rubkiewicz S
    J Heart Valve Dis; 1998 Sep; 7(5):488-99. PubMed ID: 9793844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Age dependence of the response of blood pressure, heart rate and plasma renin activity to captopril in essential hypertension].
    Stanek B; Silberbauer K
    Acta Med Austriaca; 1984; 11(3-4):101-5. PubMed ID: 6089491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catecholamines and heart function in heart transplant patients: effects of beta1- versus nonselective beta-blockade.
    Leenen FH; Davies RA; Fourney A
    Clin Pharmacol Ther; 1998 Nov; 64(5):522-35. PubMed ID: 9834044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discordance of anti-ischemic and hemodynamic effects of captopril in stable coronary artery disease.
    Winkelmann BR; Matheis G; Kleist P; Pötter S; Wohltmann D; Kaltenbach M
    Coron Artery Dis; 1994 Oct; 5(10):829-44. PubMed ID: 7866603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship of resting and exercise blood pressure in subjects with essential hypertension before and after drug treatment with propranolol.
    Potempa KM; Folta A; Braun LT; Szidon JP
    Heart Lung; 1992; 21(6):509-14. PubMed ID: 1446996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of food intake on pharmacodynamics and plasma concentration of captopril.
    Müller HM; Overlack A; Heck I; Kolloch R; Stumpe KO
    J Hypertens Suppl; 1985 Nov; 3(2):S135-6. PubMed ID: 3910768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural adaptation of the heart in borderline hypertensives in response to blood pressure lowering with captopril.
    Henderson RJ; Cranswick RW; Hunyor SN
    J Hypertens; 1994 Jan; 12(1):65-72. PubMed ID: 8157946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isometric exercise before and after nadolol treatment in uncomplicated essential hypertension.
    Corea L; Bentivoglio M; Provvidenza M
    Int J Clin Pharmacol Res; 1984; 4(1):35-40. PubMed ID: 6469432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive efficacy and safe use of once-daily sustained-release diltiazem in the elderly: a comparison with captopril. The Dilcacomp Study Group.
    Nicaise J; Neveux E; Blondin P
    J Int Med Res; 1995; 23(4):244-53. PubMed ID: 7589767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drug effects on myocardial oxygen consumption, systolic arterial pressure, diastolic arterial pressure and heart rate at rest and during exercise: comparison of enalapril and captopril].
    Striano U; Salituri S
    Cardiologia; 1988 Sep; 33(9):841-6. PubMed ID: 2852539
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.